Shapiro Lucy
Insider CIK 1435944 · PACB Director · ANAC Director · GPRO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PACB PACIFIC BIOSCIENCES OF CAL | A Award deriv | 2025-06-04 | 2025-06-06 | 65,000 | — | $0 | 65,000 | SEC↗ |
| PACB PACIFIC BIOSCIENCES OF CAL | A Award deriv | 2024-06-18 | 2024-06-20 | 32,179 | — | $0 | 32,179 | SEC↗ |
| PACB PACIFIC BIOSCIENCES OF CAL | A Award | 2024-06-18 | 2024-06-20 | 22,821 | — | $0 | 22,821 | SEC↗ |
| PACB PACIFIC BIOSCIENCES OF CAL | A Award deriv | 2023-05-24 | 2023-05-26 | 25,775 | — | $0 | 25,775 | SEC↗ |
| PACB PACIFIC BIOSCIENCES OF CAL | A Award deriv | 2022-05-25 | 2022-05-27 | 63,015 | — | $0 | 63,015 | SEC↗ |
| PACB PACIFIC BIOSCIENCES OF CAL | A Award deriv | 2021-06-16 | 2021-06-21 | 12,885 | — | $0 | 12,885 | SEC↗ |
| PACB PACIFIC BIOSCIENCES OF CAL | S Sale | 2021-02-12 | 2021-02-17 | 101,666 | $50.40 | $5.12M | 0 | SEC↗ |
| PACB PACIFIC BIOSCIENCES OF CAL | A Award deriv | 2020-08-04 | 2020-08-06 | 97,785 | — | $0 | 97,785 | SEC↗ |
| PACB PACIFIC BIOSCIENCES OF CAL | A Award deriv | 2018-05-22 | 2018-05-23 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PACB PACIFIC BIOSCIENCES OF CAL | A Award deriv | 2017-05-24 | 2017-05-25 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | D To issuer deriv | 2016-06-24 | 2016-06-24 | 7,500 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | D To issuer deriv | 2016-06-24 | 2016-06-24 | 813 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | D To issuer deriv | 2016-06-24 | 2016-06-24 | 4,096 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | D To issuer | 2016-06-24 | 2016-06-24 | 794 | $99.25 | $78.8K | 0 | SEC↗ |
| PACB PACIFIC BIOSCIENCES OF CAL | A Award deriv | 2016-05-17 | 2016-05-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PACB PACIFIC BIOSCIENCES OF CAL | M Exercise deriv | 2016-01-22 | 2016-01-26 | 25,000 | — | $0 | 0 | SEC↗ |
| PACB PACIFIC BIOSCIENCES OF CAL | M Exercise deriv | 2016-01-22 | 2016-01-26 | 35,000 | — | $0 | 0 | SEC↗ |
| PACB PACIFIC BIOSCIENCES OF CAL | M Exercise deriv | 2016-01-22 | 2016-01-26 | 25,000 | — | $0 | 0 | SEC↗ |
| PACB PACIFIC BIOSCIENCES OF CAL | M Exercise deriv | 2016-01-22 | 2016-01-26 | 16,666 | — | $0 | 8,334 | SEC↗ |
| PACB PACIFIC BIOSCIENCES OF CAL | M Exercise | 2016-01-22 | 2016-01-26 | 16,666 | $5.79 | $96.5K | 101,666 | SEC↗ |
| PACB PACIFIC BIOSCIENCES OF CAL | M Exercise | 2016-01-22 | 2016-01-26 | 25,000 | $4.45 | $111.3K | 95,000 | SEC↗ |
| PACB PACIFIC BIOSCIENCES OF CAL | M Exercise | 2016-01-22 | 2016-01-26 | 25,000 | $2.54 | $63.5K | 70,000 | SEC↗ |
| PACB PACIFIC BIOSCIENCES OF CAL | M Exercise | 2016-01-22 | 2016-01-26 | 35,000 | $1.93 | $67.5K | 35,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2015-06-09 | 2015-06-11 | 4,096 | — | $0 | 4,096 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award | 2015-06-09 | 2015-06-11 | 794 | — | $0 | 794 | SEC↗ |
| PACB PACIFIC BIOSCIENCES OF CAL | A Award deriv | 2015-05-20 | 2015-05-21 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | G Gift | 2014-12-24 | 2014-12-29 | 28,000 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2014-12-12 | 2014-12-12 | 5,447 | $34.48 | $187.8K | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2014-12-12 | 2014-12-12 | 44,384 | $34.45 | $1.53M | 28,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2014-12-11 | 2014-12-12 | 30,801 | $34.91 | $1.08M | 5,447 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2014-12-11 | 2014-12-12 | 120,032 | $34.92 | $4.19M | 72,384 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise deriv | 2014-12-10 | 2014-12-12 | 687 | $17.14 | $11.8K | 813 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise deriv | 2014-12-10 | 2014-12-12 | 834 | $0.60 | $500 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise deriv | 2014-12-10 | 2014-12-12 | 3,000 | $7.25 | $21.8K | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise deriv | 2014-12-10 | 2014-12-12 | 3,000 | $5.54 | $16.6K | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise deriv | 2014-12-10 | 2014-12-12 | 15,000 | $5.11 | $76.7K | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise deriv | 2014-12-10 | 2014-12-12 | 12,500 | $5.20 | $65.0K | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise deriv | 2014-12-10 | 2014-12-12 | 7,500 | $14.22 | $106.7K | 7,500 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise deriv | 2014-12-10 | 2014-12-12 | 15,000 | $6.74 | $101.1K | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise deriv | 2014-12-10 | 2014-12-12 | 30,000 | $6.92 | $207.6K | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise deriv | 2014-12-10 | 2014-12-12 | 1,500 | $7.55 | $11.3K | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2014-12-10 | 2014-12-12 | 1,500 | $35.79 | $53.7K | 36,248 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise | 2014-12-10 | 2014-12-12 | 1,500 | $7.55 | $11.3K | 37,748 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2014-12-10 | 2014-12-12 | 30,000 | $35.79 | $1.07M | 36,248 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise | 2014-12-10 | 2014-12-12 | 30,000 | $6.92 | $207.6K | 66,248 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2014-12-10 | 2014-12-12 | 15,000 | $35.79 | $536.9K | 36,248 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise | 2014-12-10 | 2014-12-12 | 15,000 | $6.74 | $101.1K | 51,248 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2014-12-10 | 2014-12-12 | 7,500 | $35.79 | $268.4K | 36,248 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise | 2014-12-10 | 2014-12-12 | 7,500 | $14.22 | $106.7K | 43,748 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2014-12-10 | 2014-12-12 | 12,500 | $35.79 | $447.4K | 36,248 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise | 2014-12-10 | 2014-12-12 | 12,500 | $5.20 | $65.0K | 48,748 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2014-12-10 | 2014-12-12 | 15,000 | $35.79 | $536.9K | 36,248 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise | 2014-12-10 | 2014-12-12 | 15,000 | $5.11 | $76.7K | 51,248 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2014-12-10 | 2014-12-12 | 834 | $35.79 | $29.8K | 36,248 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2014-12-10 | 2014-12-12 | 3,000 | $35.79 | $107.4K | 36,248 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise | 2014-12-10 | 2014-12-12 | 3,000 | $7.25 | $21.8K | 39,248 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise | 2014-12-10 | 2014-12-12 | 687 | $17.14 | $11.8K | 36,935 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2014-12-10 | 2014-12-12 | 687 | $35.79 | $24.6K | 36,248 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise | 2014-12-10 | 2014-12-12 | 3,000 | $5.54 | $16.6K | 39,248 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2014-12-10 | 2014-12-12 | 3,000 | $35.79 | $107.4K | 36,248 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise | 2014-12-10 | 2014-12-12 | 834 | $0.60 | $500 | 37,082 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2014-05-29 | 2014-05-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PACB PACIFIC BIOSCIENCES OF CAL | A Award deriv | 2014-05-22 | 2014-05-23 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2014-03-21 | 2014-03-25 | 80,000 | $21.14 | $1.69M | 192,416 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2014-02-07 | 2014-02-21 | 1,500 | — | $0 | 1,500 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2013-06-06 | 2013-06-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PACB PACIFIC BIOSCIENCES OF CAL | A Award deriv | 2013-05-21 | 2013-06-12 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2013-04-19 | 2013-04-19 | 10,000 | $7.98 | $79.8K | 287,416 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2013-04-19 | 2013-04-19 | 15,000 | $8.04 | $120.6K | 272,416 | SEC↗ |
| ANAC Anacor Pharmaceuticals Inc | S Sale | 2013-03-22 | 2013-03-22 | 10,000 | $6.88 | $68.8K | 297,416 | SEC↗ |
| ANAC Anacor Pharmaceuticals Inc | S Sale | 2013-03-22 | 2013-03-22 | 10,000 | $6.94 | $69.4K | 307,416 | SEC↗ |
| ANAC Anacor Pharmaceuticals Inc | S Sale | 2012-10-05 | 2012-10-05 | 15,000 | $6.66 | $99.9K | 317,416 | SEC↗ |
| ANAC Anacor Pharmaceuticals Inc | S Sale | 2012-10-03 | 2012-10-05 | 15,000 | $6.69 | $100.3K | 332,416 | SEC↗ |
| ANAC Anacor Pharmaceuticals Inc | S Sale | 2012-10-01 | 2012-10-01 | 14,400 | $6.54 | $94.2K | 347,416 | SEC↗ |
| ANAC Anacor Pharmaceuticals Inc | S Sale | 2012-09-28 | 2012-10-01 | 5,600 | $6.65 | $37.2K | 361,816 | SEC↗ |
| ANAC Anacor Pharmaceuticals Inc | S Sale | 2012-09-26 | 2012-09-28 | 10,000 | $6.58 | $65.8K | 367,416 | SEC↗ |
| ANAC Anacor Pharmaceuticals Inc | S Sale | 2012-09-24 | 2012-09-24 | 10,000 | $6.35 | $63.5K | 377,416 | SEC↗ |
| ANAC Anacor Pharmaceuticals Inc | S Sale | 2012-09-21 | 2012-09-24 | 10,000 | $6.30 | $63.0K | 387,416 | SEC↗ |
| PACB PACIFIC BIOSCIENCES OF CAL | A Award deriv | 2012-09-12 | 2012-09-12 | 35,000 | — | $0 | 35,000 | SEC↗ |
| GPRO GEN PROBE INC | D To issuer deriv | 2012-08-01 | 2012-08-02 | 7,500 | $39.51 | $296.3K | 0 | SEC↗ |
| GPRO GEN PROBE INC | D To issuer deriv | 2012-08-01 | 2012-08-02 | 7,500 | $37.10 | $278.3K | 0 | SEC↗ |
| GPRO GEN PROBE INC | D To issuer deriv | 2012-08-01 | 2012-08-02 | 7,500 | — | $0 | 0 | SEC↗ |
| GPRO GEN PROBE INC | D To issuer deriv | 2012-08-01 | 2012-08-02 | 20,000 | $26.90 | $538.0K | 0 | SEC↗ |
| GPRO GEN PROBE INC | D To issuer | 2012-08-01 | 2012-08-02 | 1,126 | $82.75 | $93.2K | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals Inc | A Award deriv | 2012-05-30 | 2012-06-01 | 12,500 | — | $0 | 12,500 | SEC↗ |
| GPRO GEN PROBE INC | A Award | 2012-04-02 | 2012-04-04 | 48 | $67.26 | $3.2K | 1,126 | SEC↗ |
| ANAC Anacor Pharmaceuticals Inc | A Award deriv | 2012-01-12 | 2012-01-17 | 3,000 | — | $0 | 3,000 | SEC↗ |
| GPRO GEN PROBE INC | A Award | 2012-01-03 | 2012-01-05 | 55 | $58.93 | $3.2K | 1,078 | SEC↗ |